PL352462A1 - Genes of cat's calciviruses and associated vaccines, in particular recombined ones - Google Patents

Genes of cat's calciviruses and associated vaccines, in particular recombined ones

Info

Publication number
PL352462A1
PL352462A1 PL00352462A PL35246200A PL352462A1 PL 352462 A1 PL352462 A1 PL 352462A1 PL 00352462 A PL00352462 A PL 00352462A PL 35246200 A PL35246200 A PL 35246200A PL 352462 A1 PL352462 A1 PL 352462A1
Authority
PL
Poland
Prior art keywords
calciviruses
recombined
cat
genes
ones
Prior art date
Application number
PL00352462A
Other versions
PL203842B1 (en
Inventor
Jean-Christophe Franc Audonnet
Philippe Guy Nicolas Baudu
Sylvie Claudine Brunet
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9909421A external-priority patent/FR2796396A1/en
Application filed by Merial Sas filed Critical Merial Sas
Publication of PL352462A1 publication Critical patent/PL352462A1/en
Publication of PL203842B1 publication Critical patent/PL203842B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL352462A 1999-07-16 2000-07-13 Genes of cat's calciviruses and associated vaccines, in particular recombined ones PL203842B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9909421A FR2796396A1 (en) 1999-07-16 1999-07-16 New DNA encoding capsid protein of feline calcivirus, useful for producing vaccines that protect against many different strains of the virus
FR0001761A FR2796397B1 (en) 1999-07-16 2000-02-11 FELIN CALICIVIRUS GENES AND VACCINES, INCLUDING RECOMBINANT VACCINES
PCT/FR2000/002051 WO2001005934A2 (en) 1999-07-16 2000-07-13 Feline calicivirus genes and vaccines, in particular recombined vaccines

Publications (2)

Publication Number Publication Date
PL352462A1 true PL352462A1 (en) 2003-08-25
PL203842B1 PL203842B1 (en) 2009-11-30

Family

ID=26212169

Family Applications (1)

Application Number Title Priority Date Filing Date
PL352462A PL203842B1 (en) 1999-07-16 2000-07-13 Genes of cat's calciviruses and associated vaccines, in particular recombined ones

Country Status (18)

Country Link
EP (1) EP1228193B1 (en)
JP (1) JP2003515315A (en)
KR (1) KR100805807B1 (en)
AR (1) AR024771A1 (en)
AT (1) ATE384118T1 (en)
AU (1) AU6576500A (en)
BR (1) BR0012512B1 (en)
CA (1) CA2379539C (en)
DE (1) DE60037826T2 (en)
DK (1) DK1228193T3 (en)
ES (1) ES2302496T3 (en)
FR (1) FR2796397B1 (en)
HU (1) HU228708B1 (en)
MX (1) MXPA02000464A (en)
PL (1) PL203842B1 (en)
PT (1) PT1228193E (en)
TW (2) TWI295322B (en)
WO (1) WO2001005934A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823222B1 (en) 2001-04-06 2004-02-06 Merial Sas VACCINE AGAINST NILE FEVER VIRUS
FR2830535B1 (en) 2001-10-10 2003-12-19 Commissariat Energie Atomique USE OF SULFONIC, PHOSPHONIC ACIDS AS DOPANTS OF POLYANILINE AND CONDUCTIVE COMPOSITE MATERIALS BASED ON POLYANILINE
US7468273B2 (en) 2003-05-01 2008-12-23 Meial Limited Canine GHRH gene, polypeptides and methods of use
US20050214316A1 (en) 2003-11-13 2005-09-29 Brown Thomas P Methods of characterizing infectious bursal disease virus
DE602006013117D1 (en) 2005-04-25 2010-05-06 Merial Ltd NIPAH VIRUS VACCINES
MX2008001326A (en) * 2005-07-28 2008-03-19 Pfizer Prod Inc Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus.
US20080241184A1 (en) 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
US7771995B2 (en) 2005-11-14 2010-08-10 Merial Limited Plasmid encoding human BMP-7
EP2186823A1 (en) 2005-11-14 2010-05-19 Merial Limited Gene therapy for renal failure
EP2759307B1 (en) 2006-03-29 2016-11-09 Merial Limited Vaccine against Streptococci
US8603808B2 (en) 2008-05-08 2013-12-10 Merial Limited Leishmania vaccine using sand fly salivary immunogen
EP2455077B1 (en) 2009-06-17 2014-06-11 National University Corporation Kumamoto University Prophylactic and/or therapeutic agent for dysmenorrhea
WO2012145577A1 (en) 2011-04-20 2012-10-26 Merial Limited Adjuvanted rabies vaccine with improved viscosity profile
EP2714077B1 (en) 2011-06-01 2018-02-28 Merial, Inc. Needle-free administration of prrsv vaccines
SI2734230T1 (en) 2011-07-20 2019-04-30 Merial Limited Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
HUE035774T2 (en) 2011-08-12 2018-05-28 Merial Inc Vacuum-assisted preservation of biological products, in particular of vaccines
EP2827897B1 (en) 2012-03-20 2018-10-31 Merial, Inc. Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
CA2966191A1 (en) 2014-11-03 2016-05-12 Merial, Inc. Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
EP3691679A2 (en) 2017-10-06 2020-08-12 Virbac Feline vaccines conferring early protection

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
EP1026253B2 (en) * 1989-03-21 2012-12-19 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate
CA2055598C (en) * 1989-07-21 1998-12-08 Richard C. Wardley Feline calicivirus gene
US5989561A (en) * 1991-03-07 1999-11-23 Virogenetics Corporation Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
WO1996037219A1 (en) * 1995-05-23 1996-11-28 The Regents Of The University Of California Abundant extracellular products and methods for their production and use
US5858373A (en) * 1995-12-01 1999-01-12 Virogenetics Corporation Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
FR2751223B1 (en) * 1996-07-19 1998-12-04 Rhone Merieux FELIN POLYNUCLEOTIDE VACCINE FORMULA
US5861397A (en) * 1996-10-03 1999-01-19 Vical Incorporated Piperazine based cytofectins
US7255862B1 (en) * 1996-11-14 2007-08-14 Connaught Technology Corporation ALVAC/FIV constructs
US6231863B1 (en) * 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
EP0956050A1 (en) * 1997-06-12 1999-11-17 Transgene S.A. Novel lipid complexes for transferring at least a therapeutically active substance, in particular a polynucleotide into a target cell and use in gene therapy

Also Published As

Publication number Publication date
BR0012512A (en) 2002-04-02
CA2379539C (en) 2012-01-03
EP1228193A2 (en) 2002-08-07
PT1228193E (en) 2008-04-28
AU6576500A (en) 2001-02-05
PL203842B1 (en) 2009-11-30
HUP0202385A2 (en) 2002-10-28
FR2796397A1 (en) 2001-01-19
BR0012512B1 (en) 2011-05-17
DE60037826D1 (en) 2008-03-06
WO2001005934A3 (en) 2001-04-26
ATE384118T1 (en) 2008-02-15
MXPA02000464A (en) 2002-07-30
CA2379539A1 (en) 2001-01-25
KR20020015378A (en) 2002-02-27
HUP0202385A3 (en) 2004-07-28
ES2302496T3 (en) 2008-07-16
DE60037826T2 (en) 2009-03-05
HU228708B1 (en) 2013-05-28
AR024771A1 (en) 2002-10-23
TW200813221A (en) 2008-03-16
KR100805807B1 (en) 2008-02-21
WO2001005934A2 (en) 2001-01-25
DK1228193T3 (en) 2008-05-26
JP2003515315A (en) 2003-05-07
EP1228193B1 (en) 2008-01-16
TWI295322B (en) 2008-04-01
TWI316089B (en) 2009-10-21
FR2796397B1 (en) 2006-09-01

Similar Documents

Publication Publication Date Title
PL352462A1 (en) Genes of cat's calciviruses and associated vaccines, in particular recombined ones
GB9913408D0 (en) Personal care formulations
MXPA02004770A (en) Therapeutic compositions and methods of use thereof.
PL352212A1 (en) Dna vaccines for domestic and sports animals
EP1257255A4 (en) Therapeutic product, use and formulation thereof
EP1210084A4 (en) Pyridomorphinans, thienomoprhinans and use thereof
EP1181057A4 (en) Noninvasive genetic immunization, expression products therefrom, and uses thereof
HK1042504A1 (en) Human cervical cancer 1 protooncogene and protein encoded therein
IL150191A0 (en) Conformational and topological protein regulation
EP1241256A4 (en) Novel gene and use thereof
HUP0202377A3 (en) N-substituted perhydrodiazines, preparation and use thereof
HK1043606A1 (en) Plant disease resistance associated genes and uses thereof
GB9903919D0 (en) Aminophenols and their therapeutic use
HUP0203678A3 (en) Nitro-sulfobenzamide-derivatives, preparation and use thereof
IL150237A0 (en) Benzophenone glycopyranosides, preparation and therapeutic use
GB9920074D0 (en) Animal model and uses thereof
GB9930463D0 (en) Virulence gene and protein and their use
GB9930462D0 (en) Virulence gene and protein and their use
GB9908323D0 (en) Virulence gene and protein and their use
GB9926348D0 (en) Virulence gene and protein, and their use
GB9926345D0 (en) Virulence gene and protein, and their use
GB9930475D0 (en) Virulence gene and protein,and their use
GB9926351D0 (en) Virulence gene and protein, and their use
GB9930472D0 (en) Virulence gene and protein,and their use
GB9926356D0 (en) Virulence gene and protein, and their use